Filing Details
- Accession Number:
- 0001179110-18-002586
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-22 16:15:43
- Reporting Period:
- 2018-02-20
- Accepted Time:
- 2018-02-22 16:15:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1372715 | J Andrew Greenfield | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Vp Healthcare Solutions | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Acquisiton | 2018-02-20 | 10,000 | $23.15 | 59,087 | No | 4 | M | Direct | |
| Common Stock, $.01 Par Value | Acquisiton | 2018-02-20 | 5,000 | $14.39 | 64,087 | No | 4 | M | Direct | |
| Common Stock, $.01 Par Value | Acquisiton | 2018-02-20 | 5,000 | $21.55 | 69,087 | No | 4 | M | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-02-20 | 1,900 | $268.32 | 67,187 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-02-20 | 4,727 | $269.48 | 62,460 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-02-20 | 7,540 | $270.45 | 54,920 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-02-20 | 3,933 | $271.28 | 50,987 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-02-20 | 1,800 | $272.32 | 49,187 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-02-20 | 100 | $273.04 | 49,087 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2018-02-07 | 6,970 | $0.00 | 42,117 | No | 5 | G | Direct | |
| Common Stock, $.01 Par Value | Acquisiton | 2018-02-20 | 6,970 | $0.00 | 6,970 | No | 5 | G | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-02-20 | 5,000 | $0.00 | 5,000 | $14.39 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-02-20 | 10,000 | $0.00 | 10,000 | $23.15 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-02-20 | 5,000 | $0.00 | 15,000 | $21.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-02-19 | 2023-02-19 | No | 4 | M | Direct |
| 0 | 2014-05-14 | 2023-05-14 | No | 4 | M | Direct |
| 10,000 | 2015-05-14 | 2024-05-14 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 5,000 | Direct |
| Common Stock | Stock Option (right to buy) | $99.62 | 2017-05-24 | 2026-05-24 | 0 | 5,000 | Direct |
| Common Stock | Stock Option (right to buy) | $134.51 | 2018-05-15 | 2027-05-15 | 0 | 6,500 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2025-05-13 | 0 | 5,000 | Direct |
| 2026-05-24 | 0 | 5,000 | Direct |
| 2027-05-15 | 0 | 6,500 | Direct |
Footnotes
- These options became exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy shares of Common Stock under ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $267.9000 and $268.8300. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $269.0100 and $269.7700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $269.9700 and $270.8700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $270.9100 and $271.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $272.0400 and $272.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust
Billionaire Hedge Funds
